|
US2750393A
(en)
*
|
1954-12-01 |
1956-06-12 |
Sterling Drug Inc |
Iodinated 5-henzamidotetrazoles and preparation thereof
|
|
US2967194A
(en)
*
|
1958-05-15 |
1961-01-03 |
Pennsalt Chemicals Corp |
4-trifluoromethylsalicylamides
|
|
FR1526074A
(fr)
|
1967-03-22 |
1968-05-24 |
Rech S Ind S O R I Soc D |
Méthoxy-phényl-amino-2-thiazoles, leurs amides et leurs procédés de préparation
|
|
FR2088019A1
(en)
|
1970-05-08 |
1972-01-07 |
Rabot Ets David |
Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
|
|
GB1352415A
(en)
|
1970-05-03 |
1974-05-08 |
Boots Co Ltd |
Esters of substituted nicotine acids
|
|
CS173097B1
(enExample)
|
1972-12-01 |
1977-02-28 |
|
|
|
GB1400540A
(en)
*
|
1972-12-06 |
1975-07-16 |
Smith Kline French Lab |
Salicylamides and compositions thereof
|
|
US4009174A
(en)
*
|
1972-12-08 |
1977-02-22 |
The Boots Company Limited |
Esters of substituted nicotinic acids
|
|
GB1437800A
(en)
*
|
1973-08-08 |
1976-06-03 |
Phavic Sprl |
Derivatives of 2-benzamido-5-nitro-thiazoles
|
|
JPS5734314B2
(enExample)
|
1973-12-22 |
1982-07-22 |
|
|
|
GB1561350A
(en)
*
|
1976-11-05 |
1980-02-20 |
May & Baker Ltd |
Benzamide derivatives
|
|
FR2344284A1
(fr)
*
|
1976-03-17 |
1977-10-14 |
Cerm Cent Europ Rech Mauvernay |
Nouveaux composes tricycliques a cycle furannique et leur application comme antidepresseurs
|
|
GB1588242A
(en)
|
1977-10-28 |
1981-04-23 |
May & Baker Ltd |
N-(tetrazol-5-yl)-salicylamide derivatives
|
|
US4474792A
(en)
*
|
1979-06-18 |
1984-10-02 |
Riker Laboratories, Inc. |
N-Tetrazolyl benzamides and anti-allergic use thereof
|
|
JPS5721320A
(en)
|
1980-07-11 |
1982-02-04 |
Chugai Pharmaceut Co Ltd |
Blood sugar level depressing agent
|
|
JPS5775962A
(en)
|
1980-10-29 |
1982-05-12 |
Shionogi & Co Ltd |
2-alkoxybenzamide derivative
|
|
FR2493848B2
(fr)
*
|
1980-11-07 |
1986-05-16 |
Delalande Sa |
Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
|
|
JPS5869812A
(ja)
|
1981-10-22 |
1983-04-26 |
Chugai Pharmaceut Co Ltd |
血糖降下剤
|
|
JPS59139357A
(ja)
*
|
1983-01-28 |
1984-08-10 |
Torii Yakuhin Kk |
アミジン誘導体
|
|
JPS61205937A
(ja)
|
1985-03-09 |
1986-09-12 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS62142168A
(ja)
|
1985-10-16 |
1987-06-25 |
Mitsubishi Chem Ind Ltd |
チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
|
|
JPS62158252A
(ja)
|
1985-12-28 |
1987-07-14 |
Kirin Brewery Co Ltd |
４−アミノピリジンベンズアミド誘導体
|
|
CA1327358C
(en)
|
1987-11-17 |
1994-03-01 |
Morio Fujiu |
Fluoro cytidine derivatives
|
|
JP2852659B2
(ja)
|
1988-03-03 |
1999-02-03 |
富山化学工業株式会社 |
ピペラジン誘導体およびその塩
|
|
DE3822449A1
(de)
|
1988-07-02 |
1990-01-04 |
Henkel Kgaa |
Oxidationshaarfaerbemittel mit neuen kupplern
|
|
JPH03181465A
(ja)
|
1989-12-11 |
1991-08-07 |
Takeda Chem Ind Ltd |
キノリン誘導体
|
|
JPH04300832A
(ja)
|
1991-03-29 |
1992-10-23 |
Tsumura & Co |
２，４−ジアミノ−１，３，５−トリアジン誘導体を有 効成分とするロイコトリエン拮抗剤
|
|
JPH04300874A
(ja)
|
1991-03-29 |
1992-10-23 |
Tsumura & Co |
新規２，４−ジアミノ−１，３，５−トリアジン誘導体
|
|
US5258407A
(en)
*
|
1991-12-31 |
1993-11-02 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5466715A
(en)
*
|
1991-12-31 |
1995-11-14 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5273986A
(en)
*
|
1992-07-02 |
1993-12-28 |
Hoffmann-La Roche Inc. |
Cycloalkylthiazoles
|
|
JPH0627025A
(ja)
|
1992-07-06 |
1994-02-04 |
Toto Ltd |
分子認識機能膜及びこれを用いたセンサー
|
|
AU657431B2
(en)
|
1992-08-20 |
1995-03-09 |
Otsuka Pharmaceutical Co., Ltd. |
Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
|
|
AU673569B2
(en)
|
1992-12-02 |
1996-11-14 |
Pfizer Inc. |
Catechol diethers as selective PDE-IV inhibitors
|
|
EP0619116A3
(en)
|
1993-04-05 |
1994-11-23 |
Hoechst Japan |
Use of synthetic retinoids for osteopathy.
|
|
GB9307527D0
(en)
|
1993-04-13 |
1993-06-02 |
Fujisawa Pharmaceutical Co |
New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
|
|
GB9401460D0
(en)
|
1994-01-26 |
1994-03-23 |
Rhone Poulenc Rorer Ltd |
Compositions of matter
|
|
DE69523864T2
(de)
|
1994-06-21 |
2002-06-13 |
Otsuka Pharmaceutical Factory, Inc. |
PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE
|
|
US5661153A
(en)
*
|
1994-07-19 |
1997-08-26 |
Japan Energy Corporation |
1-arylpyrimidine derivatives and pharmaceutical use thereof
|
|
US5792109A
(en)
|
1994-09-01 |
1998-08-11 |
Leland L. Ladd |
Irrigation pump and system
|
|
GB9420557D0
(en)
|
1994-10-12 |
1994-11-30 |
Zeneca Ltd |
Aromatic compounds
|
|
JPH08143565A
(ja)
|
1994-11-16 |
1996-06-04 |
Fujisawa Pharmaceut Co Ltd |
ベンズアミド化合物
|
|
US5510478A
(en)
*
|
1994-11-30 |
1996-04-23 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
|
US5672750A
(en)
*
|
1994-12-16 |
1997-09-30 |
Eastman Chemical Company |
Preparation of aromatic amides from carbon monoxide, an amine and an aromatic chloride
|
|
JP2930731B2
(ja)
|
1994-12-20 |
1999-08-03 |
エフ・ホフマン−ラ ロシュ アーゲー |
アリール−及びヘテロアリール−スルホンアミド誘導体、その製造法及びエンドセリンアンタゴニストとしてのその用途
|
|
US5536718A
(en)
|
1995-01-17 |
1996-07-16 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
AR002459A1
(es)
|
1995-01-17 |
1998-03-25 |
American Cyanamid Co |
Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
|
|
US5849735A
(en)
*
|
1995-01-17 |
1998-12-15 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5696112A
(en)
|
1995-01-17 |
1997-12-09 |
American Cyanamid Company |
Fused heterocyclic azepines as vasopressin antagonists
|
|
US5700796A
(en)
|
1995-01-17 |
1997-12-23 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5532235A
(en)
|
1995-01-17 |
1996-07-02 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5753648A
(en)
|
1995-01-17 |
1998-05-19 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
WO1997036480A1
(en)
|
1996-03-29 |
1997-10-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
JPH08301760A
(ja)
|
1995-05-10 |
1996-11-19 |
Shiseido Co Ltd |
皮膚外用剤
|
|
ATE254609T1
(de)
|
1995-05-18 |
2003-12-15 |
Zeria Pharm Co Ltd |
Aminothiazolderivate, sie enthaltende arzneimittel und zwischenprodukte in der herstellung dieser verbindungen
|
|
JP3168915B2
(ja)
|
1995-05-25 |
2001-05-21 |
田辺製薬株式会社 |
医薬組成物
|
|
GB9511694D0
(en)
|
1995-06-09 |
1995-08-02 |
Fujisawa Pharmaceutical Co |
Benzamide derivatives
|
|
US5712270A
(en)
*
|
1995-11-06 |
1998-01-27 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
|
JP3735741B2
(ja)
|
1995-11-24 |
2006-01-18 |
株式会社大塚製薬工場 |
縮環ピリミジン誘導体
|
|
GB9526558D0
(en)
|
1995-12-27 |
1996-02-28 |
Fujisawa Pharmaceutical Co |
Heterobicyclic derivatives
|
|
EP0915093B1
(en)
|
1996-06-06 |
2002-11-27 |
Otsuka Pharmaceutical Factory, Inc. |
Amide derivatives
|
|
JPH10101672A
(ja)
|
1996-08-06 |
1998-04-21 |
Otsuka Pharmaceut Factory Inc |
アデノシン増強剤
|
|
JPH10101671A
(ja)
|
1996-08-08 |
1998-04-21 |
Otsuka Pharmaceut Factory Inc |
一酸化窒素合成酵素阻害剤
|
|
AUPO395396A0
(en)
|
1996-12-02 |
1997-01-02 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzamide derivatives
|
|
FR2757852B1
(fr)
*
|
1996-12-31 |
1999-02-19 |
Cird Galderma |
Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
|
|
JPH10212271A
(ja)
|
1997-01-31 |
1998-08-11 |
Zeria Pharmaceut Co Ltd |
Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
|
|
ATE324907T1
(de)
|
1997-02-07 |
2006-06-15 |
Emisphere Tech Inc |
Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
|
|
JPH10338658A
(ja)
|
1997-04-08 |
1998-12-22 |
Hoechst Marion Roussel Kk |
レチノイド作用調節剤
|
|
JPH1129480A
(ja)
|
1997-05-12 |
1999-02-02 |
Otsuka Pharmaceut Factory Inc |
縮環ピリミジン誘導体を含有する医薬組成物
|
|
DE69826286T2
(de)
|
1997-06-27 |
2005-11-24 |
Fujisawa Pharmaceutical Co., Ltd. |
Derivate mit einem aromatischen ring
|
|
RU2199532C2
(ru)
|
1997-06-27 |
2003-02-27 |
Фудзисава Фармасьютикал Ко., Лтд. |
Сульфонамидное соединение
|
|
US6613942B1
(en)
*
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US6114483A
(en)
|
1997-08-27 |
2000-09-05 |
E. I. Du Pont De Nemours And Company |
Polymerization of olefins
|
|
JPH11171848A
(ja)
|
1997-09-26 |
1999-06-29 |
Fujirebio Inc |
芳香族アミド誘導体
|
|
US6297239B1
(en)
|
1997-10-08 |
2001-10-02 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
ATE205195T1
(de)
|
1997-10-22 |
2001-09-15 |
Astrazeneca Ab |
Imidazolderivate und ihre verwendung als farnesylproteintransferase inhibitoren
|
|
JP4398585B2
(ja)
|
1997-11-12 |
2010-01-13 |
有限会社ケムフィズ |
レチノイドレセプター作用剤
|
|
ES2172939T3
(es)
|
1997-11-21 |
2002-10-01 |
Astrazeneca Uk Ltd |
Nuevos compuestos que son antagonistas de receptores acoplados a proteina g de 7-transmembrana (tm) de p2-purinoceptores.
|
|
GB9725298D0
(en)
|
1997-11-28 |
1998-01-28 |
Zeneca Ltd |
Insecticidal thiazole derivatives
|
|
DK1040108T3
(da)
|
1997-12-19 |
2004-05-24 |
Schering Ag |
Orthoanthranilamidderivater som antikoagulanter
|
|
AU759255B2
(en)
*
|
1998-01-29 |
2003-04-10 |
Amgen, Inc. |
PPAR-gamma modulators
|
|
JP3937367B2
(ja)
|
1998-02-05 |
2007-06-27 |
株式会社大塚製薬工場 |
一酸化窒素合成酵素阻害剤
|
|
JPH11292879A
(ja)
|
1998-04-08 |
1999-10-26 |
Otsuka Pharmaceut Factory Inc |
カルボキサミド誘導体
|
|
DE19816780A1
(de)
*
|
1998-04-16 |
1999-10-21 |
Bayer Ag |
Substituierte 2-Oxo-alkansäure-[2-(indol-3-yl)-ethyl]amide
|
|
GB9811969D0
(en)
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DE19830431A1
(de)
|
1998-07-08 |
2000-01-13 |
Hoechst Marion Roussel De Gmbh |
Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren
|
|
US6197798B1
(en)
*
|
1998-07-21 |
2001-03-06 |
Novartis Ag |
Amino-benzocycloalkane derivatives
|
|
JP4191825B2
(ja)
|
1998-09-10 |
2008-12-03 |
あすか製薬株式会社 |
５−アミノイソキサゾール誘導体
|
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
WO2000039118A1
(en)
|
1998-12-23 |
2000-07-06 |
Eli Lilly And Company |
Aromatic amides
|
|
CA2362401A1
(en)
|
1999-02-04 |
2000-08-10 |
Paul Fleming |
G-protein coupled heptahelical receptor binding compounds and methods of use thereof
|
|
US6610846B1
(en)
*
|
1999-03-29 |
2003-08-26 |
Hoffman-La Roche Inc. |
Heteroaromatic glucokinase activators
|
|
ES2226811T3
(es)
|
1999-03-29 |
2005-04-01 |
F. Hoffmann-La Roche Ag |
Activadores de glucoquinasa.
|
|
US6320050B1
(en)
*
|
1999-03-29 |
2001-11-20 |
Hoffmann-La Roche Inc. |
Heteroaromatic glucokinase activators
|
|
RU2242469C2
(ru)
*
|
1999-03-29 |
2004-12-20 |
Ф.Хоффманн-Ля Рош Аг |
Активаторы глюкокиназы
|
|
WO2001000579A1
(en)
|
1999-06-30 |
2001-01-04 |
Tularik Inc. |
COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
|
|
CA2381882C
(en)
|
1999-08-13 |
2011-01-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
US6596772B1
(en)
|
1999-08-27 |
2003-07-22 |
Sugen, Inc. |
Phosphate mimics and methods of treatment using phosphatase inhibitors
|
|
GB9921684D0
(en)
|
1999-09-15 |
1999-11-17 |
Zeneca Ltd |
Assays
|
|
CA2385592C
(en)
|
1999-09-17 |
2011-01-11 |
Bing-Yan Zhu |
Benzamides and related inhibitors of factor xa
|
|
CO5251397A1
(es)
|
1999-10-08 |
2003-02-28 |
Smithkline Beecham Corp |
Inhibidores de fab i
|
|
CZ20021492A3
(cs)
|
1999-11-04 |
2003-06-18 |
Ortho-Mcneil Pharmaceutical, Inc. |
Nepeptidové substituované benzothiazepiny jako antagonisté vazopresinu
|
|
WO2001035950A2
(en)
*
|
1999-11-18 |
2001-05-25 |
Centaur Pharmaceuticals, Inc. |
Benzamide therapeutics and methods for treating inflammatory bowel disease
|
|
US6353111B1
(en)
|
1999-12-15 |
2002-03-05 |
Hoffmann-La Roche Inc. |
Trans olefinic glucokinase activators
|
|
ATE311366T1
(de)
*
|
2000-02-29 |
2005-12-15 |
Millennium Pharm Inc |
Benzamide und ähnliche inhibitoren vom faktor xa
|
|
EP1132381A1
(en)
|
2000-03-08 |
2001-09-12 |
Cermol S.A. |
Ester derivatives of dimethylpropionic acid and pharmaceutical compositions containing them
|
|
AU776053B2
(en)
|
2000-03-31 |
2004-08-26 |
Astellas Pharma Inc. |
Diazepan derivatives or salts thereof
|
|
US6534651B2
(en)
*
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
|
DE60113247T2
(de)
|
2000-05-03 |
2006-06-22 |
F. Hoffmann-La Roche Ag |
Hydantoin-enthaltende glucokinase aktivatoren
|
|
CA2407416C
(en)
*
|
2000-05-03 |
2006-07-18 |
Paige Erin Mahaney |
Alkynyl phenyl heteroaromatic glucokinase activators
|
|
ATE280163T1
(de)
|
2000-05-08 |
2004-11-15 |
Hoffmann La Roche |
Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
|
|
BR0110703A
(pt)
|
2000-05-08 |
2003-01-28 |
Hoffmann La Roche |
Amida, composição farmacêutica que compreende um composto, compostos, utilização de compostos, processos para o tratamento profilático ou terapêutico de diabetes do tipo ii e para a preparação desses compostos
|
|
EA005976B1
(ru)
|
2000-06-28 |
2005-08-25 |
Туларик Инк. |
Хинолинил и бензотиазолил ppar-гамма модуляторы
|
|
DE60111534T2
(de)
|
2000-07-20 |
2006-05-11 |
F. Hoffmann-La Roche Ag |
Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
|
|
US6369232B1
(en)
|
2000-08-15 |
2002-04-09 |
Hoffmann-La Roche Inc. |
Tetrazolyl-phenyl acetamide glucokinase activators
|
|
WO2002024682A1
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
|
EP1322637A2
(en)
|
2000-09-29 |
2003-07-02 |
Millennium Pharmaceuticals, Inc. |
Quaternary amidino based inhibitors of factor xa
|
|
WO2002026718A2
(en)
|
2000-09-29 |
2002-04-04 |
Millennium Pharmaceutical, Inc. |
Bicyclic pyrimidin-4-one based inhibitors of factor xa
|
|
US20040058903A1
(en)
|
2000-10-05 |
2004-03-25 |
Hisashi Takasugi |
Benzamide compounds as apo b secretion inhibitors
|
|
DE60118774T2
(de)
|
2000-11-22 |
2007-03-15 |
Astellas Pharma Inc. |
Substituierte phenolderivate und deren salze als hemmstoffe von koagulations faktor x
|
|
JP4109111B2
(ja)
*
|
2000-12-06 |
2008-07-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
縮合複素環式芳香族グルコキナーゼアクチベーター
|
|
US6482951B2
(en)
|
2000-12-13 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Isoindolin-1-one glucokinase activators
|
|
GB0031301D0
(en)
|
2000-12-21 |
2001-01-31 |
Ici Plc |
Process for the production of fluoromethyl hexafluoroisopropyl ether
|
|
EP1344525A4
(en)
*
|
2000-12-22 |
2005-05-25 |
Ishihara Sangyo Kaisha |
ANILINE DERIVATIVES OR ITS SALTS AND CYTOKINE PRODUCTION INHIBITORS CONTAINING THEM
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
US20040077697A1
(en)
|
2001-02-02 |
2004-04-22 |
Hiroyuki Koshio |
2-Acylaminothiazole derivative or its salt
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
DE60221505D1
(de)
|
2001-03-30 |
2007-09-13 |
Millennium Pharm Inc |
FAKTOR Xa BENZAMIDIN INHIBITOREN
|
|
SE0102300D0
(sv)
*
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
SE0102299D0
(sv)
*
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
BR0211810A
(pt)
*
|
2001-08-09 |
2004-08-24 |
Ono Pharmaceutical Co |
Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo
|
|
TWI325302B
(en)
|
2001-08-13 |
2010-06-01 |
Du Pont |
Benzoxazinone compounds
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
ATE355293T1
(de)
|
2001-09-12 |
2006-03-15 |
Pharmacia & Upjohn Co Llc |
Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten
|
|
TWI283164B
(en)
|
2001-09-21 |
2007-07-01 |
Du Pont |
Anthranilamide arthropodicide treatment
|
|
GEP20074098B
(en)
|
2001-09-21 |
2007-05-10 |
Bristol Myers Squibb Co |
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
|
|
US7544690B2
(en)
|
2001-10-01 |
2009-06-09 |
Taisho Pharmaceutical Co., Ltd. |
MCH receptor antagonists
|
|
EP1336607A1
(en)
|
2002-02-19 |
2003-08-20 |
Novo Nordisk A/S |
Amide derivatives as glucokinase activators
|
|
AU2002349299A1
(en)
|
2001-12-03 |
2003-06-17 |
Novo Nordisk A/S |
Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
|
|
AU2002365611A1
(en)
|
2001-12-05 |
2003-06-17 |
F. Hoffmann - La Roche Ag |
Inflammation modulators
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
DE10161765A1
(de)
*
|
2001-12-15 |
2003-07-03 |
Bayer Cropscience Gmbh |
Substituierte Phenylderivate
|
|
US6911545B2
(en)
|
2001-12-19 |
2005-06-28 |
Hoffman-La Roche Inc. |
Crystals of glucokinase and methods of growing them
|
|
US20030171411A1
(en)
|
2001-12-21 |
2003-09-11 |
Kodra Janos Tibor |
Amide derivatives as therapeutic agents
|
|
GB0202873D0
(en)
|
2002-02-07 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
|
JP4419571B2
(ja)
|
2002-03-26 |
2010-02-24 |
萬有製薬株式会社 |
新規アミノベンズアミド誘導体
|
|
CN100357283C
(zh)
|
2002-04-02 |
2007-12-26 |
中国科学院上海药物研究所 |
一类甲硫氨酰氨肽酶抑制剂
|
|
AU2003232204B8
(en)
|
2002-04-26 |
2009-07-30 |
F. Hoffmann-La Roche Ag |
Substituted phenylacetamides and their use as glucokinase activators
|
|
EP1518925A4
(en)
|
2002-05-16 |
2006-01-04 |
Banyu Pharma Co Ltd |
GLUCOKINASE PROTEIN CRYSTAL AND METHOD FOR THE DRUG CONSTRUCTION USING THE CRYSTAL
|
|
EP1531815B1
(en)
|
2002-06-27 |
2014-09-24 |
Novo Nordisk A/S |
Glucokinase activators
|
|
AU2003252478A1
(en)
*
|
2002-07-10 |
2004-02-02 |
Ono Pharmaceutical Co., Ltd. |
Ccr4 antagonist and medicinal use thereof
|
|
WO2004022536A1
(en)
|
2002-09-04 |
2004-03-18 |
Glenmark Pharmaceuticals Limited |
New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
|
RU2005113713A
(ru)
|
2002-10-03 |
2006-01-20 |
Новартис АГ (CH) |
Замещенные (тиазол-2-ил)амиды или сульфонамиды в качестве активаторов глюкокиназы, которые могут применяться при лечении диабета типа 2
|
|
ATE374768T1
(de)
|
2002-10-03 |
2007-10-15 |
Hoffmann La Roche |
Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0226930D0
(en)
*
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
PE20040801A1
(es)
|
2002-12-12 |
2004-11-25 |
Hoffmann La Roche |
Derivados de pirazina y piridina 5-sustituidos como activadores de glucoquinasa
|
|
WO2004063194A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Heteroaryl compounds
|
|
WO2004063179A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Substituted arylcyclopropylacetamides as glucokinase activators
|
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
|
JP4621198B2
(ja)
|
2003-02-11 |
2011-01-26 |
プロシディオン・リミテッド |
トリ（シクロ）置換アミドグルコキナーゼ活性化化合物
|
|
WO2004081001A1
(ja)
|
2003-02-13 |
2004-09-23 |
Banyu Pharmaceutical Co., Ltd. |
新規２－ピリジンカルボキサミド誘導体
|
|
WO2004076420A1
(ja)
*
|
2003-02-26 |
2004-09-10 |
Banyu Pharmaceutical Co., Ltd. |
ヘテロアリールカルバモイルベンゼン誘導体
|
|
CA2517888C
(en)
|
2003-03-14 |
2012-05-01 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
|
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
|
MXPA05010081A
(es)
|
2003-03-24 |
2005-11-23 |
Hoffmann La Roche |
Bencil-piridazinonas como inhibidores de transcriptasa inversa.
|
|
MXPA05012281A
(es)
|
2003-05-14 |
2006-05-19 |
Torreypines Therapeutics Inc |
Compuestos y uso de los mismos en la modulacion beta amiloide.
|
|
WO2004110375A2
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes
|
|
EP1673355A1
(en)
|
2003-09-22 |
2006-06-28 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
|
EP1675844A1
(en)
|
2003-10-23 |
2006-07-05 |
Sterix Limited |
Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
|
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
|
EP1684762A4
(en)
*
|
2003-11-13 |
2009-06-17 |
Ambit Biosciences Corp |
UREA DERIVATIVES AS MODULATORS OF KINASE
|
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
|
GB0327761D0
(en)
*
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
|
GB0327760D0
(en)
*
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
|
GB0328178D0
(en)
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Compounds
|
|
EP1702919B1
(en)
|
2003-12-29 |
2012-05-30 |
Msd K.K. |
Novel 2-heteroaryl-substituted benzimidazole derivative
|
|
DK1723128T3
(da)
|
2004-01-06 |
2013-02-18 |
Novo Nordisk As |
Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
|
|
AU2005214132B9
(en)
*
|
2004-02-18 |
2009-06-25 |
Astrazeneca Ab |
Benzamide derivatives and their use as glucokinae activating agents
|
|
CA2554686A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Compounds
|
|
US7687502B2
(en)
|
2004-03-23 |
2010-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Substituted quinazoline or pyridopyrimidine derivative
|
|
JP2007530631A
(ja)
|
2004-04-02 |
2007-11-01 |
ノバルティス アクチエンゲゼルシャフト |
チアゾロピリジン誘導体、それを含む医薬組成物およびグルコキナーゼ介在性状態の処置法
|
|
CA2560689C
(en)
|
2004-04-02 |
2011-03-01 |
Novartis Ag |
Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
|
|
CA2563192A1
(en)
|
2004-04-21 |
2005-11-03 |
Prosidion Limited |
Tri(cyclo) substituted amide compounds
|
|
TW200600086A
(en)
*
|
2004-06-05 |
2006-01-01 |
Astrazeneca Ab |
Chemical compound
|
|
JP2008502658A
(ja)
|
2004-06-17 |
2008-01-31 |
ノボ ノルディスク アクティーゼルスカブ |
肝臓選択的グルコキナーゼ活性化因子の使用
|
|
US7745491B2
(en)
|
2004-08-12 |
2010-06-29 |
Prosidion Limited |
Substituted phenylacetamides and their use as glucokinase activators
|
|
GB0418046D0
(en)
|
2004-08-12 |
2004-09-15 |
Prosidion Ltd |
Eantioselective process
|
|
GB0418058D0
(en)
|
2004-08-12 |
2004-09-15 |
Prosidion Ltd |
Fluorination process
|
|
JP4894518B2
(ja)
|
2004-09-13 |
2012-03-14 |
小野薬品工業株式会社 |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
GB0423044D0
(en)
*
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
|
GB0423043D0
(en)
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
|
MX2007004560A
(es)
|
2004-10-16 |
2007-06-08 |
Astrazeneca Ab |
Proceso para hacer compuestos de fenoxi benzamida.
|
|
WO2006066613A1
(en)
|
2004-12-24 |
2006-06-29 |
Telecom Italia S.P.A. |
Method of optimising web page access in wireless networks
|
|
AU2006239632B2
(en)
|
2005-04-25 |
2012-03-15 |
Merck Patent Gmbh |
Novel AZA- heterocycles serving as kinase inhibitors
|
|
EP1891069A1
(en)
|
2005-05-24 |
2008-02-27 |
AstraZeneca AB |
2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators
|
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
|
KR20110084339A
(ko)
*
|
2005-07-09 |
2011-07-21 |
아스트라제네카 아베 |
당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체
|
|
JP2009500442A
(ja)
|
2005-07-09 |
2009-01-08 |
アストラゼネカ アクチボラグ |
２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
|
|
EP2027113A1
(en)
|
2005-07-09 |
2009-02-25 |
AstraZeneca AB |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
|
JP2009504621A
(ja)
|
2005-08-09 |
2009-02-05 |
アストラゼネカ アクチボラグ |
糖尿病の処置のためのヘテロアリールカルバモイルベンゼン誘導体
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
BRPI0615948A2
(pt)
|
2005-09-07 |
2011-05-31 |
Plexxikon Inc |
composto ativo de ppar, sua composição, seu kit e seu uso
|
|
US20090105263A1
(en)
*
|
2005-09-16 |
2009-04-23 |
Peter William Rodney Caulkett |
Heterobicyclic compounds as glucokinase activators
|
|
CN101316837A
(zh)
|
2005-11-01 |
2008-12-03 |
詹森药业有限公司 |
作为葡萄糖激酶变构调节剂的取代的吡咯酮类
|
|
TW200738621A
(en)
|
2005-11-28 |
2007-10-16 |
Astrazeneca Ab |
Chemical process
|
|
WO2007105637A1
(ja)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
TW200825063A
(en)
*
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CL2007003061A1
(es)
|
2006-10-26 |
2008-08-01 |
Astrazeneca Ab |
Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
|
|
WO2008075073A1
(en)
|
2006-12-21 |
2008-06-26 |
Astrazeneca Ab |
Novel crystalline compound useful as glk activator
|